- Home
- BESS vs LSTA Comparison
BESS vs LSTA Comparison
Compare BESS & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BESS | LSTA |
|---|---|---|
| Founded | 1998 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Misc Health and Biotechnology Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 28.9M |
| IPO Year | 2022 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BESS | LSTA |
|---|---|---|
| Price | $3.35 | $1.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 69.1K | ★ 465.4K |
| Earning Date | 03-31-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | ★ N/A | N/A |
| Revenue | $168,880.00 | ★ $35,283,868.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 56.90 |
| 52 Week Low | $2.00 | $0.99 |
| 52 Week High | $6.45 | $5.07 |
Technical Indicators
Market Signals| Indicator | BESS | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 47.38 | N/A |
| Support Level | $2.72 | N/A |
| Resistance Level | $5.09 | N/A |
| Average True Range (ATR) | 0.36 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 32.55 | 0.00 |
Price Performance
Historical ComparisonAbout BESS Bimergen Energy Corporation Common Stock
Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.